COMFORT IMPRAIM: Open Payments
NPI 1144610239 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 19 payments from 7 companies in 2025. Trend: 2023 $703 · 2024 $737 · 2025 $410
Food & beverage: $383Education: $27
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $29 |
Products named: COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR, INGREZZA, VRAYLAR, UZEDY.
Industry payments across AZ — which companies pay providers there.
